Jamison Private Wealth Management Inc. Sells 188 Shares of Albemarle Co. (NYSE:ALB)

Jamison Private Wealth Management Inc. cut its holdings in shares of Albemarle Co. (NYSE:ALB) by 3.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,575 shares of the specialty chemicals company’s stock after selling 188 shares during the quarter. Jamison Private Wealth Management Inc.’s holdings in Albemarle were worth $394,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pathway Financial Advisers LLC raised its position in shares of Albemarle by 9,108.7% in the 3rd quarter. Pathway Financial Advisers LLC now owns 574,805 shares of the specialty chemicals company’s stock valued at $54,440,000 after buying an additional 568,563 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in Albemarle by 38.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,020,590 shares of the specialty chemicals company’s stock valued at $96,660,000 after purchasing an additional 282,194 shares in the last quarter. FMR LLC raised its position in Albemarle by 67.3% during the third quarter. FMR LLC now owns 658,145 shares of the specialty chemicals company’s stock valued at $62,333,000 after purchasing an additional 264,756 shares in the last quarter. International Assets Investment Management LLC lifted its stake in Albemarle by 7,667.4% during the third quarter. International Assets Investment Management LLC now owns 163,659 shares of the specialty chemicals company’s stock worth $155,000,000 after purchasing an additional 161,552 shares during the last quarter. Finally, Empower Advisory Group LLC boosted its holdings in shares of Albemarle by 28.7% in the 3rd quarter. Empower Advisory Group LLC now owns 705,719 shares of the specialty chemicals company’s stock valued at $66,839,000 after purchasing an additional 157,319 shares in the last quarter. 92.87% of the stock is currently owned by institutional investors and hedge funds.

Albemarle Trading Down 1.2 %

ALB opened at $88.71 on Monday. Albemarle Co. has a twelve month low of $71.97 and a twelve month high of $143.19. The company has a fifty day moving average of $96.87 and a 200-day moving average of $93.64. The stock has a market cap of $10.43 billion, a PE ratio of -5.30, a price-to-earnings-growth ratio of 3.19 and a beta of 1.58. The company has a quick ratio of 1.58, a current ratio of 2.44 and a debt-to-equity ratio of 0.43.

Wall Street Analysts Forecast Growth

ALB has been the subject of several recent analyst reports. Royal Bank of Canada upped their price objective on Albemarle from $108.00 to $133.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. Oppenheimer dropped their target price on shares of Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a report on Friday, November 8th. KeyCorp decreased their price target on shares of Albemarle from $132.00 to $127.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. Clarkson Capital assumed coverage on shares of Albemarle in a research note on Tuesday, January 14th. They issued a “buy” rating and a $112.00 price objective for the company. Finally, Mizuho decreased their target price on shares of Albemarle from $110.00 to $105.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $115.65.

Insider Transactions at Albemarle

In other news, CEO J Kent Masters sold 2,525 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The shares were sold at an average price of $101.12, for a total transaction of $255,328.00. Following the completion of the sale, the chief executive officer now owns 73,747 shares of the company’s stock, valued at $7,457,296.64. This trade represents a 3.31 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.38% of the company’s stock.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.